Cargando…
Effectiveness of high-flow nasal cannula therapy on clinical outcomes in adults with COVID-19: A systematic review
INTRODUCTION/BACKGROUND: Coronavirus disease 2019 (COVID-19) has high transmissibility and mortality rates. High-flow nasal cannula therapy (HFNC) might reduce the need for orotracheal intubation, easing the burden on the health system caused by COVID-19. The objective of the present study was to ex...
Autores principales: | Arruda, Daiana Gonçalves, Kieling, George Alvício, Melo-Diaz, Lucélia Luna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Canadian Society of Respiratory Therapists
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854387/ https://www.ncbi.nlm.nih.gov/pubmed/36741308 http://dx.doi.org/10.29390/cjrt-2022-005 |
Ejemplares similares
-
The ROX index: “Propelled” by high-flow nasal cannula therapy during the COVID-19 pandemic into greater applicability in respiratory support
por: Melo-Diaz, Lucélia Luna, et al.
Publicado: (2022) -
High-flow nasal cannula oxygen therapy in adults
por: Nishimura, Masaji
Publicado: (2015) -
High-flow nasal cannula therapy for adult patients
por: Zhang, Jian, et al.
Publicado: (2016) -
Flow Wave Interpretation of High-Flow Nasal Cannula
por: Marín, Toni, et al.
Publicado: (2021) -
A Systematic Review of the High-flow Nasal Cannula for Adult Patients
por: Helviz, Yigal, et al.
Publicado: (2018)